FORTSCHRITTSBERICHT JAHR 2006 - Helmholtz-Zentrum für ...
FORTSCHRITTSBERICHT JAHR 2006 - Helmholtz-Zentrum für ...
FORTSCHRITTSBERICHT JAHR 2006 - Helmholtz-Zentrum für ...
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Entwicklungen auf <strong>Zentrum</strong>sebene<br />
JRG Structure and Function of Antibiotics (SFA)<br />
Head: Dr. Dirk Menche<br />
Research in this group is centred around various aspects of natural product chemistry and antiinfective<br />
research, ranging from natural product isolation, the development of new synthetic<br />
methods to novel strategies in natural product synthesis, and analogue design. A particular<br />
emphasis is placed on novel antimalarial structures from African medicinal plants. Another<br />
major activity is directed towards novel methodologies to synthesize chiral amines, key structural<br />
elements of a multitude of antiinfectives, in only one chemical (stereoselective) transformation<br />
from readily available building blocks.<br />
RG Microbial Drugs (MWI)<br />
Head: Prof. Dr. Rolf Müller<br />
The research group aims to mine genomic information and biodiversity for the production of<br />
novel and altered natural products with various biological activities. Using molecular biological<br />
tools under development for gliding bacteria and having various genome data plus a most<br />
important myxobacterial strain collection at hand, the enormous genomic potential to make<br />
novel metabolites will be exploited. Biosynthetic as well as fermentation studies of known<br />
compounds are performed to provide substances for further development and increase/alter<br />
production in natural hosts. Enzymes involved in the respective biosynthesis are used in<br />
chemoenzymatic approaches to enable natural product syntheses. Uncommon habitats are<br />
screened for the presence of novel classes of gliding bacteria to provide new sources for lead<br />
structures for the screening process. In parallel, tools are developed to heterologously produce<br />
valuable compounds in more ameneable foreign host organisms.<br />
55